Photo by sharonmccutcheon from unsplash
Pathogenic variants in SCN1A can give rise to extremely variable disease severities that may be indistinguishable at their first presentation. We aim to find clinical features that can help predict… Click to show full abstract
Pathogenic variants in SCN1A can give rise to extremely variable disease severities that may be indistinguishable at their first presentation. We aim to find clinical features that can help predict the evolution of seizures into Dravet syndrome and clinical features that predict cognitive outcome in Dravet syndrome. We specifically investigate the role of contraindicated medication (CIM) as a possible modifier of cognitive decline.
Keywords:
contraindicated medication;
cognitive outcome;
dravet syndrome;
seizure;
outcome dravet
Journal Title: Epilepsia
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Epilepsia
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!